ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,638Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 551

$783K Total Retail Price of All Prescriptions

Rank: 35 out of 551

657 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
6% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 657 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

6% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

2% of this provider’s 15,797 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $35 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
RANITIDINE HCL 1,107 777 1 8
SIMVASTATIN 1,057 809 2 1
METFORMIN HCL 869 617 3 2
ENALAPRIL MALEATE 745 631 4 5
OMEPRAZOLE 720 500 5 7
GABAPENTIN 633 445 6 3
LOSARTAN POTASSIUM 480 399 7 6
TRAMADOL HCL-ACETAMINOPHEN 478 345 8 18
PRAVASTATIN SODIUM 441 343 9 24
LEVOTHYROXINE SODIUM 435 379 10 9
GLIMEPIRIDE 381 310 11 16
TRAMADOL HCL 365 264 12 32
FUROSEMIDE 337 287 13 13
ATENOLOL 334 259 14 12
FAMOTIDINE 331 280 15 31
HYDROCHLOROTHIAZIDE 320 227 16 15
METOPROLOL TARTRATE 313 253 17 17
AMLODIPINE BESYLATE 305 218 18 4
SYNTHROID 305 217 18 11
LOSARTAN-HYDROCHLOROTHIAZIDE 290 233 20 10
CARVEDILOL 281 235 21 22
ZOLPIDEM TARTRATE 278 204 22 27
DOXAZOSIN MESYLATE 265 235 23 25
OXYCODONE-ACETAMINOPHEN 257 74 S2 24 102
ALENDRONATE SODIUM 245 211 25 19
CAPTOPRIL 224 145 26 63
NABUMETONE 220 127 27 37
CLOPIDOGREL 199 168 28 30
TAMSULOSIN HCL 196 163 29 38
INSULIN SYRINGE 186 128 30 41
PREDNISOLONE 182 118 10 31 118
ISOSORBIDE MONONITRATE ER 182 127 31 21
PLAVIX 165 140 33 33
GEMFIBROZIL 165 91 33 61
NOVOLIN 70-30 155 109 35 172
CLOTRIMAZOLE-BETAMETHASONE 151 114 36 49
LISINOPRIL 150 89 37 14
SERTRALINE HCL 149 106 38 43
VERAPAMIL ER 147 115 39 39
AZITHROMYCIN 144 91 40 55
GLIPIZIDE 139 87 41 20
DIGOXIN 134 103 42 44
DONEPEZIL HCL 131 126 43 50
CLONIDINE HCL 128 118 44 60
FINASTERIDE 126 111 45 82
MECLIZINE HCL 124 102 46 56
LANTUS 123 103 47 28
PANTOPRAZOLE SODIUM 116 92 48 36
EVISTA 113 93 49 52
FLUTICASONE PROPIONATE 102 75 50 66
AMLODIPINE BESYLATE-BENAZEPRIL 96 86 51 42
CIPROFLOXACIN HCL 96 79 51 54
ALLOPURINOL 93 53 53 84
HYDROCODONE-ACETAMINOPHEN 92 19 S3 54 167
PAROXETINE HCL 88 70 55 77
ADVAIR DISKUS 88 81 55 97
NAPROXEN 85 61 57 80
LATANOPROST 84 72 58 121
WARFARIN SODIUM 83 74 59 46
PROAIR HFA 83 63 59 92
LOVASTATIN 82 66 61 68
LEVOTHROID 80 57 62 140
ENDOCET 78 38 S2 63 157
LEVOXYL 77 46 64 40
CRESTOR 73 62 65 62
BETAMETHASONE DIPROPIONATE 73 55 65 127
HUMULIN 70-30 71 38 67 35
HYDROXYZINE PAMOATE 68 42 R 68 324
AMITRIPTYLINE HCL 67 45 R 69 96
CYMBALTA 66 22 70 105
SPIRIVA 65 60 71 133
SINGULAIR 64 49 72 58
RAMIPRIL 63 43 73 53
HUMALOG MIX 75-25 63 31 73 110
NAMENDA 62 62 75 94
LYRICA 60 31 76 86
DIPYRIDAMOLE 59 58 R 77 76
CILOSTAZOL 58 34 78 64
LANSOPRAZOLE 58 25 78 72
LEVEMIR 57 34 80 210
TIZANIDINE HCL 55 19 81 138
ISOSORBIDE DINITRATE 51 50 82 100
ZETIA 50 41 83 69
ATORVASTATIN CALCIUM 50 18 83 29
DIOVAN 50 48 83 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.